Reuters Health Report

Click to View in Browser 01/14/2014 South Carolina lawmakers take aim at healthcare law CHARLESTON, South Carolina (Reuters) - South Carolina lawmakers say they have found a way to stop implementation of the U.S. Affordable Care Act in their state, an effort that could provide a template for other Republican-led legislatures looking to derail the federal program. Drugmaker AstraZeneca forecasts faster return to growth LONDON (Reuters) - AstraZeneca expects new drugs and a recent diabetes deal to offset a wave of patent expiries and return it to growth faster than analysts predict, with 2017 revenue likely to be broadly in line with the 2013 level. Richter dismisses talk it is a takeover target for Forest BUDAPEST (Reuters) - Hungarian drugmaker Richter has dismissed as "entirely unrealistic" market speculation that U.S. peer Forest Laboratories Inc might consider it as a potential takeover target. Denmark's Novo Nordisk sued in U.S. over generic Prandin COPENHAGEN (Reuters) - Denmark's Novo Nordisk has been sued by a group of healthcare purchasing companies in the United States for allegedly wrongfully keeping generic copies of its Prandin diabetes drug off the market. French birth rate falls below two children per woman PARIS (Reuters) - France's birth rate fell under the symbolically important bar of two children per woman and the country saw its lowest population growth in a decade in 2013, data showed on Tuesday in a blow to one of its economic strengths. China doctor gets suspended death sentence for trafficking newborn babies BEIJING (Reuters) - A Chinese court on Tuesday handed down a suspended death sentence on a doctor who sold seven newborn babies to human traffickers, a case that sparked widespread anger in a country where child trafficking is rampant. Tens of thousands cleared to start using water in West Virginia (Reuters) - West Virginia officials on Tuesday lifted a ban on drinking tap water from 35,000 customers who had been affected by a chemical spill that left the state's water supply nearly unusable for hundreds of thousands since last week. FDA staff cautious about J&J's latest Xarelto application (Reuters) - The U.S. Food and Drug Administration appears skeptical that data submitted by Johnson & Johnson proves its anticoagulant Xarelto is effective in reducing the risk of further heart problems in patients who have suffered a heart attack. Regeneron, Bayer to co-develop Eylea combination treatment (Reuters) - U.S. based-Regeneron Pharmaceuticals Inc and Germany's Bayer AG said they would co-develop an antibody for use in combination with Eylea, their treatment for a form of age-related blindness. Penis pumps cost U.S. government millions, watchdog cries waste WASHINGTON (Reuters) - Penis pumps cost the U.S. government's Medicare program $172 million between 2006 and 2011, about twice as much as the consumer would have paid at the retail level, according to a government watchdog's report released on Monday. Related Video Brazilian inventor sows seeds for farmers' success Elephant warning system to help humans in harm's way The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend